Ireland· IE-PA-PA1701/012/002
Edoxaban Zentiva 30 mg film-coated tablets
A edoxaban product containing edoxaban tosylate monohydrate, registered in Ireland by Zentiva k.s.. The same ATC class is registered in 17 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Edoxaban is registered in 17 of 19 countries.
Countries holding a registration under ATC B01AF03 (edoxaban), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 10 of them publish a price we can compare per daily dose
Edoxaban · ATC B01AF03
17 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of edoxaban costs, country by country.
Normalised to the WHO defined daily dose (60 mg), so markets compare like for like.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Edoxaban · price per daily dose (60 mg)
USD · FX 28 Sept 2026
- IT Italy$7.87
- CH Switzerland$6.81
The record
At a glance
HPRA (Ireland)- Active substance
- Edoxaban tosylate monohydrate
- Manufacturer
- Zentiva k.s.
- Country
- Ireland (IE)
- ATC code
- B01AF03
- ATC class
- Edoxaban
- Defined daily dose
- 60 mg, O
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberPA1701/012/002
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
262 interactions on record for edoxaban.
Graded by severity as the source publishes them — 182 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Edoxaban · interactions on record
262 records
- 182 severe
- 80 moderate
Most severe, free to view
- RolapitantA04AD14severe
- EliglustatA16AX10severe
- DicoumarolB01AA01severe
- WarfarinB01AA03severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Edoxaban in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaDELIANDAKrka, d.d., Novo mesto, Novo mesto
- SwedenEdoflusio 30 mg Filmdragerad tablettSandoz A/S
- NetherlandsEdoxaban Cipla 30 mg, filmomhulde tablettenCipla Europe N.V.
- SwitzerlandEdoxaban NOBEL 30 mg, FilmtablettenNOBEL Pharma Schweiz AG
- SpainEDOXABAN ALMUS 30 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFGAlmus Farmaceutica S.A.U.
- FinlandEdoxaban AvansorAvansor Pharma Oy
- PolandDeliandaKrka, d.d., Novo mesto
- IcelandEdoxaban AccordAccord Healthcare B.V.
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Edoflusio, Edoxaban !@ctavis
- Belgium · Edoxaban Hcs, Edoxaban Sandoz
- Bulgaria · Edoflusio, Делианда
- Czechia · Delianda, Edoxaban +pharma
- Germany · Edoxaban 1 A Pharma, Edoxaban 123 Acurae Pharma
- Denmark · Arelzamio, Dijuga
- Estonia · Delianda, Edoflusio
- Spain · Edoxabán Almus, Edoxabán Cinfa
- Finland · Edoxaban Avansor, Edoxaban Krka
- France · Oblonela
- United Kingdom (Northern Ireland) · Edoxaban, Edoxaban Accord
- Greece · Delianda, Edoxaban Pharmapath
- Croatia · Cagluen, Delianda
- Hungary · Cagluen, Delianda
- Iceland · Edoxaban Accord, Edoxaban Krka
- Italy · Edoxaban Dr. Reddy’s, Edoxaban Hcs
- Liechtenstein · Lixiana, Roteas
- Lithuania · Delianda, Edoflusio
- Luxembourg · Oblonela
- Latvia · Delianda, Edoflusio
- Malta · Arelzamio, Dijuga
- Netherlands · Edoxaban Cipla, Edoxaban G.L. Pharma
- Norway · Edoxaban Krka, Edoxaban Sandoz
- Poland · Delianda, Edoflusio
- Portugal · Edoxabano Bluepharma, Edoxabano Kern Pharma
- Romania · Cagluen, Delianda
- Sweden · Edoflusio, Edoxaban Avansor
- Slovenia · Delianda, Edoflusio
- Slovakia · Delianda, Edoxaban Accord
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b7fa32af-e9bb-4429-a646-9197e6fdba1b GET /v1/drugs/b7fa32af-e9bb-4429-a646-9197e6fdba1b?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Film-coated tablet",
"routes": [
"Oral use"
],
"source": "hpra",
"atc_all": [
"B01AF03"
],
"strength": null,
"pa_number": "PA1701/012/002",
"substances": [
"Edoxaban tosylate monohydrate"
],
"legal_basis": "Generic application (Article 10(1) of Directive No 2001/83/EC)",
"market_info": "Not marketed",
"authorised_at": "07/03/2025",
"dispensing_status": "Product subject to prescription which may be renewed (B)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about edoxaban.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.